Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This track will explore the intricate genetic mechanisms underlying various neurological disorders. Emphasis will be placed on the identification of gene mutations and their contributions to disease pathways.
This session will focus on the intersection of neurogenetics and clinical practice, highlighting how genetic insights can inform neurological diagnoses. Discussions will include case studies and advancements in neurogenetic research.
This track will delve into specific gene mutations associated with neurological disorders, examining their functional implications. Participants will discuss recent findings and methodologies for mutation analysis.
This session aims to elucidate the genetic pathways involved in the development of neurological conditions. Presentations will cover both hereditary and sporadic disorders, providing a comprehensive overview of genetic influences.
This track will investigate the genetic factors contributing to neurodevelopmental disorders, focusing on early diagnosis and intervention strategies. The role of genetic screening in identifying at-risk populations will also be discussed.
This session will explore the role of synaptic gene regulation in maintaining neurological health and function. Researchers will present findings on how dysregulation can lead to various neurological disorders.
This track will highlight the application of molecular neuroscience techniques to dissect genetic contributions to brain disorders. Topics will include gene expression profiling and functional genomics in neurological research.
This session will focus on the relationship between genetic variations and their phenotypic manifestations in neurological disorders. Presentations will emphasize the importance of understanding these correlations for precision medicine.
This track will examine the role of genetic factors in the identification and validation of neurological biomarkers. Discussions will include the implications of these biomarkers for diagnosis and treatment monitoring.
This session will explore the application of functional genomics in understanding the genetic basis of neurological disorders. Researchers will share innovative approaches to studying gene function and regulation in the nervous system.
This track will discuss the integration of clinical genetics and molecular diagnostics in the management of neurological disorders. Emphasis will be placed on the role of genetic testing in guiding treatment decisions and improving patient outcomes.